Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Metabolite profiling of the fermentation process of "yamahai-ginjo-shikomi" Japanese sake.

Tatsukami Y, Morisaka H, Aburaya S, Aoki W, Kohsaka C, Tani M, Hirooka K, Yamamoto Y, Kitaoka A, Fujiwara H, Wakai Y, Ueda M.

PLoS One. 2018 Jan 3;13(1):e0190040. doi: 10.1371/journal.pone.0190040. eCollection 2018.

2.

Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality.

Onuki T, Ueda S, Yamaoka M, Sekiya Y, Yamada H, Kawakami N, Araki Y, Wakai Y, Saito K, Inagaki M, Matsumiya N.

Can Respir J. 2017;2017:6014967. doi: 10.1155/2017/6014967. Epub 2017 Mar 13.

3.

Identification of 4-mercapto-4-methylpentan-2-one as the characteristic aroma of sake made from low-glutelin rice.

Iizuka-Furukawa S, Isogai A, Kusaka K, Fujii T, Wakai Y.

J Biosci Bioeng. 2017 Feb;123(2):209-215. doi: 10.1016/j.jbiosc.2016.09.002. Epub 2016 Oct 20.

PMID:
27773607
4.

Neurological Symptoms of Sarcoidosis-induced Small Fiber Neuropathy Effectively Relieved with High-dose Steroid Pulse Therapy.

Saito H, Yamaguchi T, Adachi Y, Yamashita T, Wakai Y, Saito K, Shinohara Y, Suzuki K, Yagihashi S, Terada J, Tatsumi K.

Intern Med. 2015;54(10):1281-6. doi: 10.2169/internalmedicine.54.3702. Epub 2015 May 15.

5.

Vacuolar morphology of Saccharomyces cerevisiae during the process of wine making and Japanese sake brewing.

Izawa S, Ikeda K, Miki T, Wakai Y, Inoue Y.

Appl Microbiol Biotechnol. 2010 Sep;88(1):277-82. doi: 10.1007/s00253-010-2758-1. Epub 2010 Jul 13.

PMID:
20625715
6.
7.

Cell surface receptor-specific scaffold requirements for adhesion to laminin-derived peptide-chitosan membranes.

Hozumi K, Otagiri D, Yamada Y, Sasaki A, Fujimori C, Wakai Y, Uchida T, Katagiri F, Kikkawa Y, Nomizu M.

Biomaterials. 2010 Apr;31(12):3237-43. doi: 10.1016/j.biomaterials.2010.01.043. Epub 2010 Feb 1.

PMID:
20122724
8.

[S-1 activity in non-small cell lung cancer in clinical practice].

Inagaki M, Onuki T, Iguchi K, Ogata T, Hayashi Y, Saito K, Wakai Y, Takabe K, Shinohara Y, Suzuki K, Ohtani T, Horikoshi K.

Gan To Kagaku Ryoho. 2009 May;36(5):763-7. Japanese.

PMID:
19461174
9.

Water absorption characteristics and structural properties of rice for sake brewing.

Mizuma T, Kiyokawa Y, Wakai Y.

J Biosci Bioeng. 2008 Sep;106(3):258-62. doi: 10.1263/jbb.106.258.

PMID:
18930002
10.

Fecal microbiota of a dugong (Dugong dugong) in captivity at Toba Aquarium.

Tsukinowa E, Karita S, Asano S, Wakai Y, Oka Y, Furuta M, Goto M.

J Gen Appl Microbiol. 2008 Feb;54(1):25-38.

11.

Water-absorption rate equation of rice for brewing sake.

Mizuma T, Tomita A, Kitaoka A, Kiyokawa Y, Wakai Y.

J Biosci Bioeng. 2007 Jan;103(1):60-5.

PMID:
17298902
12.

Efficient extraction of thioreodoxin from Saccharomyces cerevisiae by ethanol.

Inoue Y, Nomura W, Takeuchi Y, Ohdate T, Tamasu S, Kitaoka A, Kiyokawa Y, Masutani H, Murata K, Wakai Y, Izawa S, Yodoi J.

Appl Environ Microbiol. 2007 Mar;73(5):1672-5. Epub 2007 Jan 5.

13.

Polymyositis associated with infliximab treatment for rheumatoid arthritis.

Urata Y, Wakai Y, Kowatari K, Nitobe T, Mizushima Y.

Mod Rheumatol. 2006;16(6):410-1. Epub 2006 Dec 20. No abstract available.

PMID:
17165006
14.

In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.

Takeda S, Nakai T, Wakai Y, Ikeda F, Hatano K.

Antimicrob Agents Chemother. 2007 Mar;51(3):826-30. Epub 2006 Dec 4.

15.

Distribution of storage proteins in low-glutelin rice seed determined using a fluorescent antibody.

Furukawa S, Mizuma T, Kiyokawa Y, Masumura T, Tanaka K, Wakai Y.

J Biosci Bioeng. 2003;96(5):467-73.

PMID:
16233557
16.

Characterization of a multigene-encoded sodium/hydrogen antiporter (sha) from Pseudomonas aeruginosa: its involvement in pathogenesis.

Kosono S, Haga K, Tomizawa R, Kajiyama Y, Hatano K, Takeda S, Wakai Y, Hino M, Kudo T.

J Bacteriol. 2005 Aug;187(15):5242-8.

17.

Characterization of Rat8 localization and mRNA export in Saccharomyces cerevisiae during the brewing of Japanese sake.

Izawa S, Takemura R, Ikeda K, Fukuda K, Wakai Y, Inoue Y.

Appl Microbiol Biotechnol. 2005 Nov;69(1):86-91. Epub 2005 Oct 20.

PMID:
15803312
18.

Canine trachealis muscle shortening and cartilage mechanics.

Robinson PJ, Schellenberg RR, Wakai Y, Road J, Paré PD.

J Appl Physiol (1985). 2004 Mar;96(3):1063-8. Epub 2003 Oct 31.

19.

Annual changes of urinary progesterone and estradiol-17beta of the Dugong (Dugong dugon) in captivity.

Wakai Y, Hasegawa K, Sakamoto S, Asano S, Watanabe G, Taya K.

Zoolog Sci. 2002 Jun;19(6):679-82.

PMID:
12130796
20.

Mechanism of therapeutic effectiveness of cefixime against typhoid fever.

Matsumoto Y, Ikemoto A, Wakai Y, Ikeda F, Tawara S, Matsumoto K.

Antimicrob Agents Chemother. 2001 Sep;45(9):2450-4.

21.

Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).

Wakai Y, Matsui J, Koizumi K, Tsunoda S, Makimoto H, Ohizumi I, Taniguchi K, Kaiho S, Saito H, Utoguchi N, Tsutsumi Y, Nakagawa S, Ohsugi Y, Mayumi T.

Jpn J Cancer Res. 2000 Dec;91(12):1319-25.

22.

Purification and characterization of isoamyl acetate-hydrolyzing esterase encoded by the IAH1 gene of Saccharomyces cerevisiae from a recombinant Escherichia coli.

Fukuda K, Kiyokawa Y, Yanagiuchi T, Wakai Y, Kitamoto K, Inoue Y, Kimura A.

Appl Microbiol Biotechnol. 2000 May;53(5):596-600.

PMID:
10855721
23.

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.

Matsumoto S, Wakai Y, Nakai T, Hatano K, Ushitani T, Ikeda F, Tawara S, Goto T, Matsumoto F, Kuwahara S.

Antimicrob Agents Chemother. 2000 Mar;44(3):619-21.

24.

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.

Ikeda F, Wakai Y, Matsumoto S, Maki K, Watabe E, Tawara S, Goto T, Watanabe Y, Matsumoto F, Kuwahara S.

Antimicrob Agents Chemother. 2000 Mar;44(3):614-8.

25.

Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy.

Tsunoda S, Ohizumi I, Matsui J, Koizumi K, Wakai Y, Makimoto H, Tsutsumi Y, Utoguchi N, Taniguchi K, Saito H, Harada N, Ohsugi Y, Mayumi T.

Br J Cancer. 1999 Dec;81(7):1155-61.

26.

In vivo antibacterial activity of FK041, a new orally active cephalosporin.

Tawara S, Hatano K, Wakai Y, Matsumoto S, Watanabe Y, Matsumoto F, Kuwahara S.

J Antibiot (Tokyo). 1999 Jul;52(7):660-5.

27.

Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesis.

Ohizumi I, Taniguchi K, Saito H, Kawata H, Tsunoda S, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Utoguchi N, Kaiho S, Ohsugi Y, Mayumi T.

Int J Cancer. 1999 Sep 9;82(6):853-9.

28.

Tumor vascular targeting using a tumor-tissue endothelium-specific monoclonal antibody as an effective strategy for cancer chemotherapy.

Makimoto H, Koizumi K, Tsunoda S, Wakai Y, Matsui J, Tsutsumi Y, Nakagawa S, Ohizumi I, Taniguchi K, Saito H, Utoguchi N, Ohsugi Y, Mayumi T.

Biochem Biophys Res Commun. 1999 Jul 5;260(2):346-50.

PMID:
10403773
29.

Balance of activities of alcohol acetyltransferase and esterase in Saccharomyces cerevisiae is important for production of isoamyl acetate.

Fukuda K, Yamamoto N, Kiyokawa Y, Yanagiuchi T, Wakai Y, Kitamoto K, Inoue Y, Kimura A.

Appl Environ Microbiol. 1998 Oct;64(10):4076-8.

30.

Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells.

Ohizumi I, Tsunoda S, Taniguchi K, Saito H, Esaki K, Koizumi K, Makimoto H, Wakai Y, Matsui J, Tsutsumi Y, Nakagawa S, Utoguchi N, Ohsugi Y, Mayumi T.

Int J Cancer. 1998 Aug 12;77(4):561-6.

31.

Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.

Ohizumi I, Tsunoda S, Taniguchi K, Saito H, Esaki K, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Utoguchi N, Kaiho S, Ohsugi Y, Mayumi T.

Biochem Biophys Res Commun. 1997 Jul 18;236(2):493-6.

PMID:
9240467
32.

Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen.

Utoguchi N, Mizuguchi H, Dantakean A, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Mayumi T.

Br J Cancer. 1996 Jan;73(1):24-8.

33.

Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma.

Utoguchi N, Dantakean A, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Mayumi T.

Jpn J Cancer Res. 1995 Feb;86(2):193-201.

34.

Regional diaphragm shortening measured by sonomicrometry.

Wakai Y, Leevers AM, Road JD.

J Appl Physiol (1985). 1994 Dec;77(6):2791-6.

PMID:
7896623
35.

Tumor necrosis factor alpha decreases in vivo diaphragm contractility in dogs.

Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J.

Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1368-73.

PMID:
7952566
36.

Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs.

Walley KR, Hebert PC, Wakai Y, Wilcox PG, Road JD, Cooper DJ.

J Appl Physiol (1985). 1994 Mar;76(3):1060-7.

PMID:
8005845
38.

Delayed poststimulus decrease of phrenic motoneuron output produced by phrenic nerve afferent stimulation.

Road JD, Osborne S, Wakai Y.

J Appl Physiol (1985). 1993 Jan;74(1):68-72.

PMID:
8444737
39.

In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.

Mine Y, Watanabe Y, Sakamoto H, Hatano K, Wakai Y, Kamimura T, Tawara S, Matsumoto S, Matsumoto F, Kuwahara S.

J Antibiot (Tokyo). 1993 Jan;46(1):88-98.

40.

[Effect of diaphragmatic fatigue on ventilatory response to carbon dioxide].

Wakai Y, Yoshimura A, Katagiri S, Yoshino K, Konno K.

Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:133-8. Japanese.

PMID:
1306216
41.

Effect of vagal stimulation and parenteral acetylcholine on canine trachealis muscle shortening.

Okazawa M, Wakai Y, Osborne S, Paré PD, Road JD.

J Appl Physiol (1985). 1992 Jun;72(6):2463-8.

PMID:
1629103
42.

Expiratory muscle activity in the awake and sleeping human during lung inflation and hypercapnia.

Wakai Y, Welsh MM, Leevers AM, Road JD.

J Appl Physiol (1985). 1992 Mar;72(3):881-7.

PMID:
1533214
44.

Localization of cadherin cell-adhesion molecules in the skin lesion of darier disease.

Furukawa F, Miyachi Y, Wakai Y, Imamura S.

Int J Dermatol. 1991 Aug;30(8):599-600. No abstract available.

PMID:
1938063
45.

Ventilatory effects of percutaneous magnetophrenic stimulation.

Nagano A, Yoshimura A, Asado Y, Kitamura A, Wakai Y, Akutsu T, Watanabe T, Yamaguchi M, Takubo T, Yoshino K, et al.

Front Med Biol Eng. 1991;3(2):97-112.

PMID:
1911472
47.

Development and clinical application of a portable oxygen concentrator.

Akutsu T, Ishihara J, Wakai Y, Watanabe T, Yamaguchi M, Takubo T, Yoshino K, Konno K, Takizawa T.

Front Med Biol Eng. 1990;2(4):293-301.

PMID:
2081152
48.

In vivo antibacterial activity of FK482, a new orally active cephalosporin.

Mine Y, Yokota Y, Wakai Y, Kamimura T, Tawara S, Shibayama F, Kikuchi H, Kuwahara S.

J Antibiot (Tokyo). 1988 Dec;41(12):1888-95.

49.
50.

Degradation of host defenses against respiratory tract infection by Klebsiella pneumoniae in aged mice.

Yokota Y, Wakai Y, Mine Y, Goto S, Nishida M, Kuwahara S.

Infect Immun. 1988 Apr;56(4):966-71.

Supplemental Content

Support Center